NCT04204330Completed
Federal Cardiomonitoring System. Determination of the Efficiency of a Single-lead ECG Monitor.
Federal Cardiomonitoring System. Determination of the Efficiency of a Single-lead ECG Recorded with CardioQVARK Cardiac Monitor in Order to Detect Atrial Fibrillation in Primary Health Centers.
Source: ClinicalTrials.gov · Last updated 8 Oct 2024
Brief summary (registry, in English)
This interventional prospective multicenter nonrandomized clinical and epidemiological study is the first Russian study aimed at evaluating the effectiveness of a single-lead electrocardiography device (CardioQVARK) in screening for atrial fibrillation in primary health care.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 5000 (actual)
- First submitted
- 7 Dec 2019
- Start date
- 4 Mar 2019
- Primary completion date
- 3 Oct 2024
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Diseases
- Atrial fibrillation
- NCT number
- NCT04204330
What you commit to
- Study type: Interventional
- Participants enrolled: 5000
- From 4 Mar 2019 to the primary completion date, 3 Oct 2024
- 6 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Refusal of further participation in the study
Who the study is looking for
- Men and women aged 18 to 96 years who have one or more of the following risk factors:
- hypertonic disease
- history of ischemic stroke or transient ischemic attacks
- type 1 and type 2 diabetes
- 1-3 degrees obesity
- heart failure or the presence of a clinic to reduce exercise tolerance associated with shortness of breath
- coronary heart disease or the presence of symptoms of chest pain, in the absence of an established diagnosis of coronary heart disease
- the presence of peripheral arterial atherosclerosis
- the presence of a clinic of interruptions in the work of the heart (bouts of rapid, irregular heartbeats, pauses in work of heart)
- Non-inclusion criteria:
- Acute coronary syndrome
- Acute ischemic or hemorrhagic stroke
- Acute psychosis
- The presence of severe concomitant diseases with an expected life expectancy of less than 2 years
Age in the registry: 18 years to 96 years · Sex: All · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| State Budgetary Healthcare Institution of Moscow Region "Mytishchi City Clinical Hospital" Coordinator of this site? Confirm its status | Mytishchi | Russia | Unknown status |
| Clinic №4, State Budgetary Healthcare Institution of Moscow Region "Mytishchi City Clinical Hospital" Coordinator of this site? Confirm its status | Mytishchi | Russia | Unknown status |
| Branch of State Budgetary Healthcare Institution of Moscow Region "Mytishchi City Clinical Hospital" Coordinator of this site? Confirm its status | Mytishchi | Russia | Unknown status |
| Clinic №2, State Budgetary Healthcare Institution of Moscow Region "Mytishchi City Clinical Hospital" Coordinator of this site? Confirm its status | Mytishchi | Russia | Unknown status |
| Branch office of State Budgetary Healthcare Institution of Moscow Region "Mytishchi City Clinical Hospital" Coordinator of this site? Confirm its status | Mytishchi | Russia | Unknown status |
| Clinic №1, State Budgetary Healthcare Institution of Moscow Region "Mytishchi City Clinical Hospital" Coordinator of this site? Confirm its status | Mytishchi | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.